Intraventricular Hemorrhage clinical trials

Explore recruiting intraventricular hemorrhage clinical trials.

Recruiting intraventricular hemorrhage studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Intraventricular Hemorrhage trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

The effect of additional pre-extubational loading dose of caffeine-citrate

Hungary

Therapeutic use (Phase IV) EU CTIS Study details

Remifentanil for endotracheal intubation in neonates: a dose-finding trial.

Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

rFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial

Germany, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Echec-MAT - A combination of antibiotics to improve neonatal mortality and morbidity for pregnancies complicated with previable labour and intact membranes: an open multiple center, randomized, and controlled trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

EdoxabaN foR IntraCranial Hemorrhage survivors with Atrial Fibrillation

Spain, Austria, Czechia, Greece, Belgium, Italy +4 more

Therapeutic use (Phase IV) EU CTIS Study details

Low molecular weight heparin in the treatment of early fetal growth restriction – a Randomized Controlled Trial

Portugal

Therapeutic use (Phase IV) EU CTIS Study details

Intraventricular Hemorrhage trials by city

Intraventricular Hemorrhage in Toronto Intraventricular Hemorrhage in Vancouver Intraventricular Hemorrhage in Montreal Intraventricular Hemorrhage in Calgary Intraventricular Hemorrhage in Edmonton Intraventricular Hemorrhage in Ottawa Intraventricular Hemorrhage in Winnipeg Intraventricular Hemorrhage in Quebec City Intraventricular Hemorrhage in Hamilton Intraventricular Hemorrhage in Kitchener Intraventricular Hemorrhage in London Intraventricular Hemorrhage in Halifax Intraventricular Hemorrhage in New York Intraventricular Hemorrhage in Los Angeles Intraventricular Hemorrhage in Chicago Intraventricular Hemorrhage in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease